<span style="line-height: 20.8px;">Cincinnati-based&nbsp;</span><strong style="line-height: 20.8px;">Medpace Holdings Inc</strong><span style="line-height: 20.8px;">, a clinical contract research organization focused on the biotech, pharmaceutical and medical device sectors, has raised $161 million for its IPO after pricing its 7 million shares at $23 per share.</span>